Winners / 2021

ERVEBO

By: Merck & Co., Inc.
Gold

Master Category:

Award Category: Science, Medical and Dental

Award Sub-Category: Cellular Research & Disease Prevention

ERVEBO is Merck’s vaccine for the prevention of disease caused by Zaire ebolavirus in individuals 18 years of age and older. ERVEBO is the first Ebola vaccine approved by the U.S. Food & Drug Administration (FDA) and the European Medicines Agency (EMA), significant milestones in Ebola preparedness and prevention efforts.

Explore more Energy & Sustainability

Put your innovation in the spotlight.

For four decades, the Edison Awards have recognized innovative products, services, and technologies that create meaningful value and impact. Explore the categories, find the right fit, and enter your new innovation for recognition.

Ready for Nomination Season?

Complete the form below to download the 2027 Nomination Guide.

A Founders Guide to Modern Innovation
The Future of the Grid – Panel Discussion 2024 Edison Awards
Edison Award-Winning Brain Technology Featured in U.S. News & World Report